MyFinsight
Home
About
Contact
adct: the income statement
Download
Download image
Net loss
-$40,966K
(6.83%↑ Y/Y)
Loss before equity in
net losses of joint...
-$40,966K
(6.28%↑ Y/Y)
Loss before income
taxes
-$40,966K
(6.08%↑ Y/Y)
License revenues and
royalties
$677K
(51.12%↑ Y/Y)
Product revenues, net
$15,750K
(-12.58%↓ Y/Y)
Total other expense,
net
-$9,997K
(-24.11%↓ Y/Y)
Loss from operations
-$30,969K
(12.92%↑ Y/Y)
Other, net
$925K
(-43.04%↓ Y/Y)
Interest income
$2,470K
(-28.16%↓ Y/Y)
Total revenue, net
$16,427K
(-11.03%↓ Y/Y)
Interest expense
$13,392K
(2.10%↑ Y/Y)
Total operating
expense
$47,396K
(-12.28%↓ Y/Y)
Effective interest
expense on senior...
$4,396K
Deferred royalty
obligation interest...
$8,996K
(5.44%↑ Y/Y)
Restructuring and impairment
expenses
$377K
General and
administrative
$8,326K
(-16.76%↓ Y/Y)
Selling and marketing
$10,688K
(0.14%↑ Y/Y)
Research and development
$26,803K
(-17.53%↓ Y/Y)
Cost of product sales
$1,202K
(41.25%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
ADC Therapeutics SA (ADCT)
ADC Therapeutics SA (ADCT)